Life360, Inc. LIF 深 滬
等待開盤 01-28 09:30:00 美东时间
61.69
-4.290
-6.50%
華盛通- 最 高65.21
- 今 開64.51
- 成交量 121.96万股
- 最 低 60.95
- 昨 收 65.98
- 總市值 48.37亿
- 52周最高 112.5395
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 29.62
- 委 比 -89.53%
- 總股本 7840.05万
- 歷史最高 112.5395
- 量 比 0.67
- 振 幅 6.46%
- 歷史最低 26.00
- 每 手 1
- 風險率 21.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
今天 10:59
Life360 Shares Climb After Boosting FY25 Sales Guidance
Life360 Inc (NASDAQ:LIF) shares are popping on Friday after the company raised its fiscal year 2025 sales guidance.
01-24 02:49
Life360 Provides An Operational Update On Key Performance Metrics For Q4 And Full Year 2025; Life360's Global MAU Base Reached 95.8M In Q4 2025, With Full-year 2025 Net Additions Of 16.2M, A 20% Growth YoY; Says Full Year 2025 Revenue And AEBITDA To Exceed Prior Guidance
Life360, Inc. (Life360 or the Company) (NASDAQ:LIF, ASX: 360))), the provider of the market-leading family safety and connection mobile application, today provided an operational update on key performance metrics for Q4
01-23 05:31
Life360 Raises FY2025 Sales Guidance from $474.000M-$485.000M to $486.000M-$489.000M
Life360 (NASDAQ:LIF) raises FY2025 sales outlook from $474.000 million-$485.000 million to $486.000 million-$489.000 million.
01-23 05:30
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
Citigroup Maintains Buy on Life360, Lowers Price Target to $79.5
Citigroup analyst Ronald Josey maintains Life360 (NASDAQ:LIF) with a Buy and lowers the price target from $96.8 to $79.5.
01-09 23:46
Citizens Downgrades Life360 to Market Perform
Citizens analyst Andrew Boone downgrades Life360 (NASDAQ:LIF) from Market Outperform to Market Perform.
01-06 01:10
